Welcome to our dedicated page for Electromed news (Ticker: ELMD), a resource for investors and traders seeking the latest updates and insights on Electromed stock.
Electromed Inc. (ELMD) specializes in advanced airway clearance solutions through its clinically validated SmartVest system. This dedicated news hub provides investors and healthcare stakeholders with essential updates on respiratory care innovations, regulatory compliance, and corporate developments.
Find authoritative coverage of ELMD's progress in HFCWO technology, including product enhancements, partnership announcements, and quality certifications. Our curated news selection emphasizes factual reporting on clinical trial outcomes and market expansion initiatives within the medical device sector.
Regular updates include earnings disclosures, manufacturing quality milestones, and research collaborations. Bookmark this resource for streamlined access to verified ELMD developments that impact respiratory therapy standards and investment considerations.
Electromed, known for its innovative airway clearance technologies, announced that its top executives, President and CEO Jim Cunniff and CFO Brad Nagel, will attend the 2024 Sidoti June Small-Cap Virtual Conference. This event is scheduled for June 12-13, 2024. Electromed will present at 1:45 p.m. ET on June 12, 2024. A live and archived webcast of their presentation will be accessible via the Electromed website.
Electromed, Inc. achieves record revenue in the third quarter of fiscal year 2024, with a 15% increase to $13.9 million compared to the prior year. Operating income rises by 54%, net income reaches $1.49 million, and cash balance grows to $11.7 million. The company's direct homecare business revenue increases by 12%, showing strong growth and operational efficiency. The gross profit margin remains stable at 75%. Electromed continues to focus on driving adoption of its products, enhancing shareholder value, and sustaining operating leverage for profitability.